130 related articles for article (PubMed ID: 9691247)
1. 1-substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands.
Matuszczak B; Pekala E; Müller CE
Arch Pharm (Weinheim); 1998 May; 331(5):163-9. PubMed ID: 9691247
[TBL] [Abstract][Full Text] [Related]
2. New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II.
Biagi G; Giorgi I; Livi O; Scartoni V; Betti L; Giannaccini G; Trincavelli ML
Eur J Med Chem; 2002 Jul; 37(7):565-71. PubMed ID: 12126775
[TBL] [Abstract][Full Text] [Related]
3. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK
J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
[TBL] [Abstract][Full Text] [Related]
4. 4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo [4,3-alpha]-quinoxalin-1-one: a new A2A adenosine receptor antagonist with high selectivity versus A1 receptors.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
Arch Pharm (Weinheim); 1999 Feb; 332(2):39-41. PubMed ID: 10233008
[No Abstract] [Full Text] [Related]
5. [1,2,4]Triazolo[4,3-a]quinoxalin-4-amines: a new class of A1 receptor selective adenosine antagonists.
Trivedi BK; Bruns RF
J Med Chem; 1988 May; 31(5):1011-4. PubMed ID: 3361571
[TBL] [Abstract][Full Text] [Related]
6. 2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists.
Burbiel JC; Ghattas W; Küppers P; Köse M; Lacher S; Herzner AM; Kombu RS; Akkinepally RR; Hockemeyer J; Müller CE
ChemMedChem; 2016 Oct; 11(20):2272-2286. PubMed ID: 27531666
[TBL] [Abstract][Full Text] [Related]
7. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Traini C; Pugliese AM; Pedata F; Morizzo E; Moro S
Bioorg Med Chem; 2008 Jun; 16(11):6086-102. PubMed ID: 18468446
[TBL] [Abstract][Full Text] [Related]
9. Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines.
Catarzi D; Cecchi L; Colotta V; Filacchioni G; Martini C; Tacchi P; Lucacchini A
J Med Chem; 1995 Apr; 38(8):1330-6. PubMed ID: 7731018
[TBL] [Abstract][Full Text] [Related]
10. Characterization and preliminary use of 1-, 2- and 3-methyl-5-phenyl-7-chloro-1,2,3-triazolo[4,5-d]pyrimidine as reaction intermediates.
Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL
Farmaco; 2003 Aug; 58(8):551-6. PubMed ID: 12875884
[TBL] [Abstract][Full Text] [Related]
11. 1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.
Catarzi D; Colotta V; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
Farmaco; 2004 Feb; 59(2):71-81. PubMed ID: 14871498
[TBL] [Abstract][Full Text] [Related]
12. Derivatives of 4,6-diamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-2H-1-one: potential antagonist ligands for imaging the A2A adenosine receptor by positron emission tomography (PET).
Holschbach MH; Bier D; Wutz W; Sihver W; Schüller M; Olsson RA
Eur J Med Chem; 2005 May; 40(5):421-37. PubMed ID: 15893016
[TBL] [Abstract][Full Text] [Related]
13. Substituted 1,2,3-triazolo[1,5-a]quinazolines: synthesis and binding to benzodiazepine and adenosine receptors.
Bertelli L; Biagi G; Giorgi I; Livi O; Manera C; Scartoni V; Lucacchini A; Giannaccini G; Barili PL
Eur J Med Chem; 2000 Mar; 35(3):333-41. PubMed ID: 10785559
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 4-cycloalkylamino-1, 2, 4-triazolo[4, 3-a]quinoxalin-1- one derivatives as A1 and A3 adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A; Colotta V
Arch Pharm (Weinheim); 2004 Jan; 337(1):35-41. PubMed ID: 14760626
[TBL] [Abstract][Full Text] [Related]
15. 1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.
Colotta V; Catarzi D; Varano F; Calabri FR; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Deflorian F; Moro S
J Med Chem; 2004 Jul; 47(14):3580-90. PubMed ID: 15214785
[TBL] [Abstract][Full Text] [Related]
16. Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A
Falsini M; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Volpini R; Di Cesare Mannelli L; Ghelardini C; Colotta V
Bioorg Chem; 2019 Jun; 87():380-394. PubMed ID: 30913470
[TBL] [Abstract][Full Text] [Related]
17. 2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists.
Catarzi D; Colotta V; Varano F; Calabri FR; Lenzi O; Filacchioni G; Trincavelli L; Martini C; Tralli A; Montopoli C; Moro S
Bioorg Med Chem; 2005 Feb; 13(3):705-15. PubMed ID: 15653338
[TBL] [Abstract][Full Text] [Related]
18. 1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
J Med Chem; 2000 Mar; 43(6):1158-64. PubMed ID: 10737748
[TBL] [Abstract][Full Text] [Related]
19. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.
Catarzi D; Colotta V; Varano F; Calabri FR; Filacchioni G; Galli A; Costagli C; Carlà V
J Med Chem; 2004 Jan; 47(1):262-72. PubMed ID: 14695840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
